Role of Pancreatic Exocrine Secretion in Weight Gain After Pancreas Transplantation
Launched by RUSH UNIVERSITY MEDICAL CENTER · Dec 29, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at why some people gain a lot of weight after receiving a pancreas transplant. While pancreas transplants can help control blood sugar levels in patients with diabetes, many recipients experience significant weight gain, which can lead to other health issues like diabetes, heart disease, and increased risk of death. The researchers want to understand if the increased digestive juices from the new pancreas might be contributing to this weight gain. They believe that these juices help the body turn food into stored energy, leading to extra weight.
To participate in this study, you need to be between 18 and 80 years old and have received a pancreas transplant, either alone or along with other organs. Participants will undergo tests to measure certain digestive enzymes in their stool, which can help determine how their body is processing food. If the researchers confirm their theory, it could lead to new ways to manage weight gain after transplants, possibly using specific medications that target these digestive enzymes. If you're interested in learning more or considering participation, please talk to your healthcare provider.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Recipients of pancreas transplant with or without other organs
- • Age 18 - 80 yrs
- Exclusion Criteria:
- • Unwillingness to consent or participate in the study
About Rush University Medical Center
Rush University Medical Center is a leading academic medical institution located in Chicago, Illinois, dedicated to advancing healthcare through innovative research and clinical trials. As a sponsor of numerous clinical studies, Rush focuses on translating scientific discoveries into effective treatments and improving patient outcomes across a variety of medical disciplines. With a commitment to excellence in patient care, education, and research, Rush leverages its state-of-the-art facilities and a robust network of specialists to conduct comprehensive trials that adhere to the highest ethical and regulatory standards. Through collaboration with a diverse patient population, Rush aims to enhance the understanding of diseases and develop novel therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Oyedolamu Olaitan, MBBS
Principal Investigator
Rush University Medical Center
Amanda Van Jacobs, MS
Study Director
Rush University Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials